U.S. Offers & #36;1.2 Billion to Drug Company for COVID-19 Vaccine Research

FRIDAY, May 22, 2020 -- The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to AstraZeneca to develop a potential COVID-19 vaccine from a lab in Oxford, England. The fourth, and largest, vaccine...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news